NattoPharma releases Q4 2020 Trading Statement: The best quarter of 2020
Oslo, Norway (17 February 2021) Followed by a very strong first nine month of 2020, NattoPharma increased revenues in the fourth quarter by 62%, bringing the FY growth to 69% compared to the same period in 2019. The total revenue for 2020 ended up at NOK 214.5 million passing the NOK 200 million for the first in the history of the company. FY Adjusted EBITDA came in at NOK 37.3 million equal to a margin of 17.4%. Performance highlights for Q4 2020 (Q4 2019 in brackets) · Operating revenue of NOK 62.3m (NOK 38.5m) · Adjusted EBITDA of NOK 14.4m (NOK 2.2m) / Adjusted EBITDA% of